A bipartisan bill introduced in Congress Tuesday aims to force the Trump administration's hand on Medicare Part D price negotiations, and would require HHS to bargain directly with drugmakers.
privacy policy | terms of use | contact us | advertise | pharma jobs | pharma blogs | facebook | twitter
Copyright © 2024,